PHOENIX MOTOR INC. (PEVM): Nasdaq/NYSE listing notice — Phoenix Motor (PEV) gets Nasdaq extension to April 15, 2024 for bid price compliance

PHOENIX MOTOR INC.

Nasdaq granted additional 180 days to meet $1.00 minimum bid price rule; new deadline April 15, 2024.
Original non-compliance notice received April 18, 2023; initial 180-day period ended October 16, 2023.
To regain compliance, stock must close at $1.00+ for 10 consecutive business days.
Company may consider a reverse stock split if needed to cure the deficiency.
No immediate impact on listing; shares continue trading on Nasdaq under ticker PEV.

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

PHOENIX MOTOR INC. received a nasdaq extension granted notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).

Exchange: nasdaq
Notice: extension granted
Deficiency: minimum bid price
Rules: 5550(a)(2), 5810(c)(3)(A)

Exact text from the filing

October 17, 2023, the Company received a letter from Nasdaq advising that the Company had been granted a 180-day extension to April 15, 2024 to regain compliance with the Minimum Bid Price Requirement, in accordance with Nasdaq Listing Rule 5810(c)(3)(A). If at any time before April 15, 2024, the closing bid price of the Common Stock is at least $1.00 per share for a minimum of 10 consecutive business days, the Company will regain compliance with this Nasdaq rule and this matter will be closed. The Company will continue to monitor the closing bid price of its Common Stock and may, if appropria

View on SEC.gov

Browse all listing & compliance notices →

PHOENIX MOTOR INC. filing history →

Source: SEC EDGAR

accession 0001104659-23-109592

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.